Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

The Defense Health Agency (DHA) Pharmacy and Therapeutics Committee is issuing a Request for Quotation (RFQ) to obtain manufacturer quotes for pharmaceutical agents to be considered for inclusion on the DoD Uniform Formulary (UF) under new Blanket Purchase Agreements (BPAs) and/or Uniform Formulary Additional Discount Programs (ADPs). Offerors must submit a completed Manufacturer Quote Submission Checklist, verify that the Federal Supply Schedule (FSS) contract number and company name match the VA National Acquisition Center (NAC) records, and agree to work with the DoD Prime Vendor Program and, where applicable, open a limited distribution channel to Accredo for TRICARE mail‑order pharmacy. Prices must be equal to or lower than current FSS, Big‑4, and Joint National Contract (JNC) rates, be consistent across all package sizes, and remain valid for 180 days. The DHA requires additional discounts that are no greater than any existing price reductions on approved FSS or National Contract price lists. All quotes are contingent on the drug’s inclusion on the UF and will be evaluated per 32 CFR 199.21 for relative clinical and cost effectiveness, with classification into Tier 1 (generic), Tier 2 (brand) or Tier 3 (non‑formulary). Existing BPAs/ADPs for the same drug class will be terminated; new quotes must replace them. Registration, electronic submission to the RFQ point of contact, and participation in a pre‑quotation teleconference (with optional one‑on‑one technical liaison appointments) are required.

Notice ID

f14c9c8aff0f480c9a04e16bad546109

Solicitation Number

HT9402-26-Q-9101

NAICS Code

325412

Classification Code

6505